Adar Poonawalla praised Modi for giving a vision to achieve another vaccine for children
Covovax vaccine from the Serum Institute of India has been approved for children of 12-17 age group on Tuesday. Children can get vaccinated at private hospitals after getting themselves registered on COWIN portal.
Adar Poonawalla, Director of Serum Institute of India announced the approval on Twitter. He said, “Covovax, is now available for children in India. This is the only vaccine made in India which has more than 90% efficacy and this vaccine is also been sold in Europe”.
He also praised Narendra Modi for giving the vision to achieve yet another covid vaccine to protect the children. The vaccine will be available in private centres at the cost of Rs.225 including Rs.150 additional tax.
A few weeks back, Prakash Kumar Singh, Director of Government and Regulatory Affairs at Serum Institute of India requested the Union Health ministry to include Covovax for the children in the vaccination campaign.
At present, 12-14 age group children are getting vaccinated with Biological E’s intramuscular vaccine named Corbevax and children of 15-18 age groups are taking Bharat Biotech’s Covaxin. More than 60% of the population of children have been jabbed so far with Corbevax and Covaxin. The vaccination drive is being held at the Government Vaccination centres free of cost.
Last year, the vaccine Corvovax was approved by India’s Drug Controller General on December 28, 2021 to use it for emergency purpose on adults whereas on March 2022, the vaccine got approval for emergency use for children aged 12 and above which makes it the fourth vaccine to get a nod for vaccination in this age group.
Covovax (@Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of > 90%. This is in line with Shri @narendramodi Ji's vision of providing yet another vaccine to protect our children. pic.twitter.com/QUm7sZyOfi
— Adar Poonawalla (@adarpoonawalla) May 3, 2022
Share This Post On
0 comments
Leave a comment
You need to login to leave a comment. Log-in
